Scinai Immunotherapeutics LT
13F holders, Q1 2024 (March 31)13holders
2famous investors
$0.52avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Scinai Immunotherapeutics LT in their 13F filings. The largest holders were Sabby Management, LLC ($131K), Armistice Capital, LLC ($63K) and Citadel Advisors ($6K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Scinai Immunotherapeutics LT
- CUSIP
- 09073Q204
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $12K |
| Exits | 1 | $12 |
Ownership 13 holders
| Sabby Management, LLC | 0.95% | Add +14.7% | 253,135 | $131K |
| Armistice Capital, LLC | 0.00% | Reduce -47.3% | 121,785 | $63K |
| Citadel Advisors | 0.00% | New | 12,214 | $6K |
| Millennium Management | 0.00% | New | 10,613 | $5K |
| Rhumbline Advisers | 0.00% | Add +25.2% | 6,654 | $3K |
| Morgan Stanley | 0.00% | Reduce -0.1% | 2,579 | $1K |
| UBS Group AG | 0.00% | Add +0.1% | 2,118 | $1K |
| Credit Agricole S A | 0.00% | No change | 424 | $193 |
| Main Street Group, LTD | 0.00% | No change | 200 | $103 |
| Aspire Private Capital, LLC | 0.00% | No change | 160 | $83 |
| Global Retirement Partners, LLC | 0.00% | No change | 50 | $26 |
| Qube Research & Technologies Ltd | 0.00% | No change | 7 | $4 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is SCINAI IMMUNOTHERAPEUTICS LT's weight in each manager's 13F, not the share of Scinai Immunotherapeutics LT the manager owns.